Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Disetronic shares soar nearly 70% after flotation:

This article was originally published in Clinica

Executive Summary

The newly-floated shares of Swiss company Disetronic rose nearly 70% in the first days of trading on the Zurich stock exchange. The manufacturer of portable drug delivery systems priced its initial public offering at SwFr 1,350 ($1,090) a share and on June 20th, the third day of trading, the shares stood at SwFr 2,250. This values the company, based in Burgdorf, at around SwFr 500 million. The flotation raised SwFr 72 million for Disetronic from the sale of 50,000 newly issued shares. The remaining 22,000 shares were sold by existing stockholders. With a voting stake of 63%, CEO Willy Michel remains in control of the company. After the flotation, shares representing 14% of the vote and 29% of the capital are publicly owned.

You may also be interested in...

Majority Of Spanish OTC Firms Investing Heavily In Digital

A recent ANEFP survey shows that the majority of Spanish OTC firms consider their digital strategies to be "very advanced."

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

Novartis Targets Ten Indications For Cosentyx

The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts